Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2

Following the emergence of SARS-CoV-2, the search for an effective and rapidly available treatment was initiated worldwide based on repurposing of available drugs. Previous reports described the antiviral activity of certain tyrosine kinase inhibitors (TKIs) targeting the Abelson kinase 2 against pa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antiviral Res
Main Authors: Touret, Franck, Driouich, Jean-Sélim, Cochin, Maxime, Petit, Paul Rémi, Gilles, Magali, Barthélémy, Karine, Moureau, Grégory, Mahon, Francois-Xavier, Malvy, Denis, Solas, Caroline, de Lamballerie, Xavier, Nougairède, Antoine
Formato: Artigo
Idioma:Inglês
Publicado em: The Authors. Published by Elsevier B.V. 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274277/
https://ncbi.nlm.nih.gov/pubmed/34265358
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2021.105137
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados